CENTER LEADERSHIP
The Center for SMART Health draws upon experience from multiple facets of the UCLA campus, with guidance from key thought leaders and members of senior leadership from its sponsoring Institutes.
CENTER DIRECTORS
Co-Director, Center for SMART Health
Director, Medical & Imaging Informatics Group
Director, Medical Informatics Home Area
Professor, Departments of Radiological Sciences, Bioengineering & Bioinformatics
David Geffen Chair in Informatics
Dr. Bui received his PhD in Computer Science in 2000, upon which he joined the UCLA faculty. His research includes informatics and data science for biomedical research and healthcare in areas related to distributed information architectures and mHealth; development, evaluation, and translation of AI-based methods (e.g., machine learning, reinforcement learning) for healthcare; and data visualization. His work bridges contemporary computational approaches with the opportunities arising from the breadth of biomedical observations and the electronic health record (EHR), tackling the associated translational challenges.
Dr. Bui has a long history of leading extramurally funded research, including from multiple different NIH institutes (NCI, NLM, NINDS, NIBIB, NIMHD). He was Co-Director for the NIH Big Data to Knowledge (BD2K) Centers Coordination Center; Application Lead for the NSF-funded Expeditions in Computing Center for Domain-Specific Computing (CDSC), exploring cutting-edge hardware/software techniques for accelerating algorithms used in healthcare; and Director of the NIH-funded Los Angeles PRISMS Center, a U54 focused on mHealth informatics. He is also a Program Director of two separate NIH T32s at UCLA in the areas of biomedical informatics, and data science; Director of the Medical & Imaging Informatics (MII) Group; and is Co-Director of UCLA CTSI’s Informatics Program.
Dr. Arash Naeim is a Professor in Bioengineering in the Henry Saumeli School of Engineering & Applied Sciences; and a Professor of Medicine in the Divisions of Hematology-Oncology and Geriatric Medicine at the David Geffen UCLA School of Medicine. He is Chief Medical Officer for Clinical Research for the UCLA. Health. He is board certified in clinical informatics and serves as the Physician Informaticist for UCLA Health in the areas of research and oncology. He is an Associate Director of the CTSI, GIRS, and IPH. He is also a Senior Leader and Director of Informatics for the Jonsson Comprehensive Cancer Center. His research interests included outcomes research, cost-effectiveness analysis, modeling of health and frailty, and clinical trial design. His focus of research for the majority of his publications and research grants has been in breast cancer and cancer in the elderly. He is the UCLA Principal Investigator for the Athena Breast Health Network and NIH grant that aims to use sensor technology and analytics to reduce risk, integrate innovative technology, and advance precision medicine.
INSTITUTION LEADERSHIP
Dr. Steven Dubinett is Associate Vice Chancellor for Research and Director of the JCCC Lung Cancer Research Program. He has extensive experience in translational investigation, academic administration, mentorship and peer review. He is Chief, Division of Pulmonary and Critical Care Medicine and jointly appointed as Professor in the Departments of Medicine, Pathology and Laboratory Medicine, and Molecular and Medical Pharmacology. He has served on national advisory panels and committees including the NCI’s Translational Research Working Group. He has experience directing large, multidisciplinary research teams funded by the NCI SPORE program, the Early Detection Research Network and the Department of Defense. He has served as a permanent member of three different NIH study sections and numerous Special Emphasis Panels. He has been consistently funded by peer-reviewed federal resources for translational research in lung cancer for more than 20 years. He served as a member of the FDA Cellular, Tissue and Gene Therapies Advisory Committee and on several editorial boards including Clinical and Translational Science. He is an Associate Editor in Chief of the American Journal of Translational Research.
Dr. Geschwind is the Gordon and Virginia MacDonald Distinguished Professor of Human Genetics, Neurology and Psychiatry at UCLA. In his capacity as Senior Associate Dean and Associate Vice Chancellor of Precision Health, he leads the Institute for Precision Health at UCLA. His laboratory has pioneered the application of systems biology methods in neurologic and psychiatric disease. Dr. Geschwind has put considerable effort into fostering large-scale collaborative patient resources for genetic research and data sharing in autism research. He has served on numerous scientific advisory boards, including the Faculty of 1000 Medicine, the Executive Committee of the American Neurological Association, the Scientific Advisory Board for the Allen Institute for Brain Science, the NIMH Advisory Council and the NIH Council of Councils. He has published over 400 papers and serves on the editorial boards of Cell, Neuron and Science. He has received several awards for his laboratory’s work and leadership including the Ruane Prize from the Brain and Behavior Foundation in 2013 and the Derek Denny-Brown Neurological Scholar Award from the American Neurological Association (ANA) in 2004. He is an elected member of the American Association of Physicians and the National Academy of Medicine.
Dr. Ali Mosleh is Distinguished Professor and holder of the Evalyn Knight Chair in Engineering at the University of California in Los Angeles. Prior to that he was the Nicole J. Kim Eminent Professor of Engineering and Director of the Center for Risk and Reliability at the University of Maryland. Dr. Mosleh is also a Fellow of the Society for Risk Analysis, and the American Nuclear Society, recipient of several scientific achievement awards, and consultant and technical advisor to numerous national and international organizations. In 2004 he was appointed by President George W. Bush to the U.S. Nuclear Waste Technical Review Board. He continued to serve on the board under President Obama until 2012.